🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
Israeli biotech firm files for IPO

Israeli biotech drug developer Gamida Cell Ltd. has announced that it is going public to help fund clinical trials and b...

October 1, 2018 | Monday | News
DHA signs MoU with Nice University Hospital

The Dubai Health Authority (DHA) has signed a memorandum of understanding (MoU) with Nice University Hospital. The MoU ...

September 26, 2018 | Wednesday | News
Atox Bio announces completion of pre-planned safety review

Atox Bio, a clinical stage biotechnology company developing novel therapies for critically ill patients has announced th...

September 25, 2018 | Tuesday | News
Medtronic partners with Mazor Robotics

Medtronic a global leader in medical technology, and Mazor Robotics, a pioneer in the field of robotic guidance systems,...

September 24, 2018 | Monday | News
US regulator approves Teva's migraine drug

Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after th...

September 21, 2018 | Friday | News
IntelyseYou partners With Aspen for Medical Response

Intelyse, a Sicuro Group company recently announced that they have entered into a strategic partnership with Aspen Medic...

September 11, 2018 | Tuesday | News
Leviticus Cardio successfully completes its third chronic animal study

Leviticus Cardio an Israel company, which is inventors of the versatile transcutaneous Coplanar Energy Transfer (CET) sy...

September 10, 2018 | Monday | News
Israel's Together Pharma to buy 50 percent stake of German cannabis

Together Pharma, which produces medical cannabis   had signed a deal to buy a controlling 50.01 percent stake ...

August 30, 2018 | Thursday | News
Hebrew University researchers develop a drug for acute leukemia

Researchers at the Hebrew University of Jerusalem said they have developed a new biological drug that had a 50 percent c...

August 28, 2018 | Tuesday | News
Pharmax initiates operations at new Dubai facility

UAE-based Pharmax Pharmaceuticals has begun production out of its new $34 million facility located in Dubai Science Park...

August 28, 2018 | Tuesday | News
iCAN, Yom Chai signs MoU for crohn's disease and autism

Singapore - The Directors of Ananda Developments recently announced that investee company iCAN has signed an MoU with a ...

August 21, 2018 | Tuesday | News
BiondVax relocates to new manufacturing facility

BiondVax Pharmaceuticals Ltd., developer of the M-001 universal influenza vaccine candidate, recently reported the compa...

August 20, 2018 | Monday | News
FSD Pharma, SciCann Launch clinical research program in Israel

FSD Pharma announced the launch of a clinical research collaborative program in Israel, via its strategic R&D p...

August 17, 2018 | Friday | News
Middle East, Africa pharma economy to reach $38.8B by 2021

CPhI MEA (Middle East and Africa) launches next month as favourable market conditions are driving increased growth acros...

August 16, 2018 | Thursday | News
Cellect Granted Key European Patent for Its Stem Cell Selection Technology

Cellect Biotechnology Ltd., a developer of a novel stem cell production technology, announced today the European Patent ...

August 8, 2018 | Wednesday | News
DNAtix, Mapmygenome partner to advance personalized preventive medicine

Digital DNAtix Ltd., the blockchain genetics company, and Mapmygenome, a molecular diagnostics company, today announced ...

August 6, 2018 | Monday | News
HUJI gets an ultra-high resolution U-CT system

A MILabs dual-energy, ultra-high resolution U-CT system has been installed at The Hebrew University of Jerusalem Israel ...

August 3, 2018 | Friday | News
Abdi Ibrahim selects rfxcel for FMD Compliance

Abdi Ibrahim, the Turkish pharmaceutical industry leader, has carefully selected rfxcel to implement and support new com...

August 2, 2018 | Thursday | News